HROW Harrow, Inc.
$29.07▲ +0.41%
Healthcare
Other
Volume 635.4K
Avg Volume (10D) 585.8K
Key Metrics & Fundamentals
Market Cap
$1.09B
P/E Ratio
–
Div Yield
0.00%
52W Range
26.96 - 54.85
% vs 50 MA
-13.41%
% vs 200 MA
-24.74%
RSI-14
41.2
MACD Histogram
+0.3300
Beta (1Y vs SPY)
1.33
Free Cash Flow
-$10.29M
Gross Rev
$70.66M
Gross Profit
$50.36M
EBITDA
-$4.82M
COGS
$20.30M
Operating Exp
$61.37M
Operating Income
-$11.01M
EBIT
-$11.01M
Pretax Income
-$17.27M
Net Income
-$17.27M
EPS (Diluted)
-0.46
Price & Volume History
Loading chart…
Recent News
Harrow To Report Third Quarter 2026 Financial Results After Market Close on November 9, 2026
GlobeNewswire · Oct 26, 2026 7:00 AM ET
Is Harrow (HROW) Below Fair Value Based On Its Sales?
Simply Wall St. · Oct 18, 2026 11:12 AM ET
Outlook Therapeutics Names Greg DiPasquale Chief Commercial Officer
MT Newswires · Oct 9, 2026 9:12 AM ET
Do Options Traders Know Something About Harrow Stock We Don't?
Zacks · Oct 9, 2026 7:46 AM ET
Is Harrow (HROW) Undervalued On Growing Conference Buzz Around Its Ophthalmic Pipeline?
Simply Wall St. · Oct 7, 2026 9:15 PM ET
Harrow Completes Acquisition of Tyrvaya Nasal Spray From Viatris
MT Newswires · Oct 5, 2026 8:10 AM ET
Harrow Closes Acquisition of TYRVAYA®
GlobeNewswire · Oct 5, 2026 7:00 AM ET
Harrow Ophthalmic Portfolio Highlighted in 15 Scientific Presentations at AAOpt and AAO
GlobeNewswire · Sep 30, 2026 7:00 AM ET
Leerink Partners Initiates Coverage on Harrow With Outperform Rating, $45 Price Target
MT Newswires · Sep 9, 2026 7:52 AM ET
This Fund Bought Moderna Before It Nearly Tripled. See Its 2 New Stock Picks
Insider Monkey · Sep 3, 2026 10:44 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See HROW's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.